Nathaniel Calloway - Jan 9, 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca Hilt
Stock symbol
LFCR
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4
Date filed
1/11/2023, 03:21 PM
Previous filing
Nov 2, 2022
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Award +5.91K 5.91K Jan 9, 2023 Common Stock 5.91K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.